These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1353099

  • 1. Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells.
    Loeffler CM, Smyth MJ, Longo DL, Kopp WC, Harvey LK, Tribble HR, Tase JE, Urba WJ, Leonard AS, Young HA.
    J Immunol; 1992 Aug 01; 149(3):949-56. PubMed ID: 1353099
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW, Hsieh CS, Fitch FW.
    J Immunol; 1991 May 01; 146(9):3242-9. PubMed ID: 1673149
    [Abstract] [Full Text] [Related]

  • 3. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
    Fujihashi K, Yamamoto M, McGhee JR, Kiyono H.
    J Immunol; 1993 Dec 15; 151(12):6681-91. PubMed ID: 7903096
    [Abstract] [Full Text] [Related]

  • 4. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
    Nagarkatti M, Clary SR, Nagarkatti PS.
    J Immunol; 1990 Jun 15; 144(12):4898-905. PubMed ID: 1972170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Superantigen-induced anergy in cytotoxic CD8+ T cells.
    Sundstedt A, Höidén I, Hansson J, Hedlund G, Kalland T, Dohlsten M.
    J Immunol; 1995 Jun 15; 154(12):6306-13. PubMed ID: 7759869
    [Abstract] [Full Text] [Related]

  • 7. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
    den Boer AT, van Mierlo GJ, Fransen MF, Melief CJ, Offringa R, Toes RE.
    Cancer Res; 2005 Aug 01; 65(15):6984-9. PubMed ID: 16061684
    [Abstract] [Full Text] [Related]

  • 8. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
    Schoof DD, Terashima Y, Peoples GE, Goedegebuure PS, Andrews JV, Richie JP, Eberlein TJ.
    Cell Immunol; 1993 Aug 01; 150(1):114-23. PubMed ID: 8102084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
    Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET.
    J Immunol; 1995 Apr 15; 154(8):3969-74. PubMed ID: 7706735
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H, Li F, Gordon JR, Xiang J.
    Cancer Res; 2002 Apr 01; 62(7):2043-51. PubMed ID: 11929823
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.
    Gabrilovich DI, Ciernik IF, Carbone DP.
    Cell Immunol; 1996 May 25; 170(1):101-10. PubMed ID: 8665590
    [Abstract] [Full Text] [Related]

  • 15. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
    Evans R, Duffy TM, Kamdar SJ.
    Eur J Immunol; 1991 Aug 25; 21(8):1815-9. PubMed ID: 1907916
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD, Schreiber H, Bluestone JA.
    J Immunol; 1990 Apr 01; 144(7):2840-6. PubMed ID: 1969454
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
    Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T.
    J Immunol; 1991 Feb 01; 146(3):1077-82. PubMed ID: 1671050
    [Abstract] [Full Text] [Related]

  • 18. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D, Forman J.
    J Immunol; 1991 Jan 01; 146(1):3-10. PubMed ID: 1670605
    [Abstract] [Full Text] [Related]

  • 19. Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5.
    Taguchi T, Aicher WK, Fujihashi K, Yamamoto M, McGhee JR, Bluestone JA, Kiyono H.
    J Immunol; 1991 Dec 01; 147(11):3736-44. PubMed ID: 1682383
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov 01; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.